Go to  ADVANCED SEARCH
Sign In
Program Calendar
MCLE offers over 250 in-person programs annually across the Commonwealth, covering hundreds of topics and practice areas. Click here to browse MCLE's program calendar.
Best Selling Books from MCLE in Business and Commercial Law
MCLE's list of bestsellers is continually expanding. Five of the perennial favorites in Business and Commercial Law are listed below, or click here to see all of MCLE's best sellers.
Just Updated Books from MCLE in Business and Commercial Law
Through an active supplementation and revision program, MCLE strives to keep its book content fresh, current, and cutting-edge. The most recent updates to Business and Commercial Law books are listed below, or click here to see all of MCLE's recently updated books.
OnDemand mp3 Recording
 
Cutting Edge Life Sciences Law and Practice

For transactional and IP attorneys

Product Number: 2090135WAU
Recorded: 3/9/2009
Length: 4 Hours
CLE Credits: 4 substantive credits, 0 ethics credits
Copyright: 2009 MCLE, Inc.
Price: Nonmember $135.00; Sponsor $120.00
Add to cart | FAQs | Related Products

Why attend?

The life sciences industry-biotech, pharma, medical devices, bioinformatics, specialized life sciences manufacturing-in Massachusetts has been, and is expected to be for years to come, a key driver of economic growth. Lawyers in firms with life sciences clients, in-house counsel at life sciences companies, and lawyers who represent clients investing in life sciences companies need to be current on the latest developments affecting the industry.

This intermediate-to-advanced level program addresses current developments and issues affecting the life sciences industry. The expert faculty cover topics ranging from the activities of the Massachusetts Life Sciences Center in its administration of the $1 billion Life Sciences Initiative, to the key issues for parties in spinouts of life sciences companies from hospitals and universities, to critical concerns related to IP due diligence in transactions involving life sciences companies, to the evolution of patent declaratory judgment case law in the post-MedImmune era. If you are (or want to be) a transactional or IP attorney (law firm or in-house) who represents life sciences companies or investors in life sciences companies, you need to attend this program.

You will learn...

  • How the MLSC works and what opportunities the $1 billion Life Sciences Initiative offers for funding and other financial incentives for your clients
  • Why IP due diligence and appropriate communication of the results is so sensitive and critical to the life sciences company and the recipient of the due diligence analysis
  • What the key issues are for a university/hospital, venture capital investor and the transactional and IP lawyers involved in a life sciences spinout
  • How the latest developments in declaratory judgment practice post-MedImmune may impact your strategic options when asserting patents or addressing third party patents

Agenda and written materials

  • Introduction to the Massachusetts Life Sciences Center and Its Administration of the $1 Billion Life Sciences Initiative What is MLSC legally required to do? What are its plans to accomplish its responsibilities? What has it done so far
  • Conducting Effective IP Due Diligence and Communicating the Results Which issues are typically most critical to the party conducting diligence? How can lawyers communicate the information they obtain to assist decision-makers in assessing risk? How does privilege play a role as information is obtained, communicated, and used in the transaction?
  • Key Issues in University/Hospital Spinouts of Life Sciences Companies What are the key issues for the university/hospital, the venture capital firm investing in the spinout, and the lawyers involved in the transaction?
  • Developments in Declaratory Judgment Post-MedImmune in the Life Sciences Space How have the court decisions which followed in the wake of the MedImmune decision impacted the life sciences industry? What types of strategic changes do these decisions dictate for patent holders, potential licensees, and infringers?
  • "Ask the Experts" Q&A Session

Faculty


General Information

Product Number: 2090135WAU
Recorded: 3/9/2009
Length: 4 Hours
CLE Credits: 4 substantive credits, 0 ethics credits
Copyright: 2009 MCLE, Inc.
Price: Nonmember $135.00; Sponsor $120.00
Add to cart | FAQs | Related Products

Related Products

Title  
Audio CD: Cutting Edge Life Sciences Law and Practice
Nonmember: $135.00; Sponsor: $120.00 		Add to cart
OnDemand Webcast: Cutting Edge Life Sciences Law and Practice
Nonmember: $135.00; Sponsor: $120.00 		Add to cart